4//SEC Filing
Leicher Bruce 4
Accession 0001179110-18-010499
CIK 0001235010other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:31 PM ET
Size
8.7 KB
Accession
0001179110-18-010499
Insider Transaction Report
Form 4
Leicher Bruce
SVP & General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-08-08−1,346→ 13,453 total→ Common Stock (1,346 underlying) - Exercise/Conversion
Common Stock
2018-08-08+1,346→ 172,869 total - Sale
Common Stock
2018-08-08$29.00/sh−400$11,600→ 172,469 total
Footnotes (5)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]Includes 476 shares acquired under the issuer's employee stock purchase plan at a purchase price of $14.20 per share on July 31, 2018.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F4]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F5]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001345695
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:31 PM ET
- Size
- 8.7 KB